Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
ImmunityBio, Inc. (NK) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
07/21/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
05/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
03/31/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "IMMUNITYBIO, INC. CONVERTIBLE PROMISSORY NOTE"
03/20/2023 8-K Quarterly results
02/14/2023 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/13/2023 8-K Quarterly results
12/12/2022 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obl...
Docs: "Placement Agency Agreement by and between the Company and Piper Sandler & Co.",
"Form of Common Stock Purchase Warrant",
"Legal Opinion of Wilson Sonsini Goodrich & Rosati, P.C",
"Securities Purchase Agreement",
"Promissory Note between the Company and Nant Capital, LLC",
"ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor"
12/05/2022 8-K Quarterly results
11/15/2022 8-K Quarterly results
09/02/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
06/14/2022 8-K Quarterly results
03/25/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/15/2022 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Fin...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ImmunityBio Completes Acquisition of Athenex's Interest in Dunkirk, New York Advanced Biotech Manufacturing Facility"
01/12/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc.",
"ImmunityBio Expands Manufacturing Capacity with State-of-the-Art Manufacturing Plant in New York for Global Pandemic Response and Preparedness"
12/20/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Promissory Note by and between the Company and Nant Capital, LLC",
"IMMUNITYBIO ANNOUNCES COMPLETION OF $470 MILLION POST-MERGER FINANCING TO FUND LATE-STAGE CANCER CLINICAL TRIALS, PHASE 3 OF COVID T-CELL UNIVERSAL BOOST VACCINE TRIAL AND PROVIDES UPDATE ON BLADDER CANCER BLA FILING Year-End Review:"
09/27/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
09/13/2021 8-K Quarterly results
08/13/2021 8-K Quarterly results
06/15/2021 8-K Quarterly results
06/11/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
05/28/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
04/01/2021 8-K Quarterly results
03/17/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
01/13/2021 8-K Quarterly results
12/22/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Agreement and Plan of Merger, by and among NantKwest, Inc., ImmunityBio, Inc. and Nectarine Merger Sub, Inc.",
"Voting Agreement, by and among ImmunityBio, Inc., NantKwest, Inc., and the NantKwest, Inc. stockholders party thereto",
"Voting Agreement, by and among NantKwest, Inc., ImmunityBio, Inc. and the ImmunityBio, Inc. stockholders party thereto"
12/21/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "IMMUNITYBIO AND NANTKWEST TO MERGE, CREATING A LEADING IMMUNOTHERAPY AND CELL THERAPY COMPANY"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy